BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

971 related articles for article (PubMed ID: 15316861)

  • 1. Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.
    Otomo H; Sakai A; Ikeda S; Tanaka S; Ito M; Phipps RJ; Nakamura T
    J Bone Miner Metab; 2004; 22(5):404-14. PubMed ID: 15316861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene and vitamin K2 combine to improve the femoral neck strength of ovariectomized rats.
    Iwamoto J; Yeh JK; Schmidt A; Rowley E; Stanfield L; Takeda T; Sato M
    Calcif Tissue Int; 2005 Aug; 77(2):119-26. PubMed ID: 16059775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
    Yao W; Balooch G; Balooch M; Jiang Y; Nalla RK; Kinney J; Wronski TJ; Lane NE
    Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography.
    Borah B; Dufresne TE; Chmielewski PA; Gross GJ; Prenger MC; Phipps RJ
    J Bone Miner Res; 2002 Jul; 17(7):1139-47. PubMed ID: 12096826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH.
    Iwaniec UT; Samnegård E; Cullen DM; Kimmel DB
    Bone; 2001 Oct; 29(4):352-60. PubMed ID: 11595618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats.
    Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK
    Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate treatment.
    Callaci JJ; Juknelis D; Patwardhan A; Sartori M; Frost N; Wezeman FH
    Alcohol Clin Exp Res; 2004 Jan; 28(1):182-91. PubMed ID: 14745317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment with eldecalcitol (1α, 25-dihydroxy-2β- (3-hydroxypropyloxy) vitamin D3) suppresses bone turnover and leads to prevention of bone loss and bone fragility in ovariectomized rats.
    Takeda S; Smith SY; Tamura T; Saito H; Takahashi F; Samadfam R; Haile S; Doyle N; Endo K
    Calcif Tissue Int; 2015 Jan; 96(1):45-55. PubMed ID: 25467010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats.
    Iwamoto J; Takeda T; Sato Y; Yeh JK
    Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 16 weeks of treatment with tibolone on bone mass and bone mechanical and histomorphometric indices in mature ovariectomized rats with established osteopenia on a low-calcium diet.
    Yoshitake K; Yokota K; Kasugai Y; Kagawa M; Sukamoto T; Nakamura T
    Bone; 1999 Sep; 25(3):311-9. PubMed ID: 10495135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Pirie CM; Simmons HA; Chidsey-Frink KL; Chen HK; Jee WS; Thompson DD
    Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats.
    Ohnishi H; Nakamura T; Narusawa K; Murakami H; Abe M; Barbier A; Suzuki K
    Bone; 1997 Oct; 21(4):335-43. PubMed ID: 9315337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats.
    Li M; Mosekilde L; Søgaard CH; Thomsen JS; Wronski TJ
    Bone; 1995 Jun; 16(6):629-35. PubMed ID: 7669439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
    Okubo R; Sanada LS; Castania VA; Louzada MJ; de Paula FJ; Maffulli N; Shimano AC
    Osteoporos Int; 2017 Apr; 28(4):1461-1471. PubMed ID: 28124728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
    Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
    J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.